Cros S - Search Results

1

Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363.

Pierré A, Kraus-Berthier L, Atassi G, Cros S, Poupon MF, Lavielle G, Berlion M, Bizzari JP. Pierré A, et al. Among authors: cros s. Cancer Res. 1991 May 1;51(9):2312-8. Cancer Res. 1991. PMID: 2015595

2

Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.

Auclair C, Pierre A, Voisin E, Pepin O, Cros S, Colas C, Saucier JM, Verschuere B, Gros P, Paoletti C. Auclair C, et al. Among authors: cros s. Cancer Res. 1987 Dec 1;47(23):6254-61. Cancer Res. 1987. PMID: 3677074

3

In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.

Cros S, Guilbaud N, Berlion M, Dunn T, Regnier G, Dhainaut A, Atassi G, Bizzari JP. Cros S, et al. Cancer Chemother Pharmacol. 1992;30(6):491-4. doi: 10.1007/BF00685604. Cancer Chemother Pharmacol. 1992. PMID: 1394807

4

Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.

Giorgi-Renault S, Renault J, Gebel-Servolles P, Baron M, Paoletti C, Cros S, Bissery MC, Lavelle F, Atassi G. Giorgi-Renault S, et al. Among authors: cros s. J Med Chem. 1991 Jan;34(1):38-46. doi: 10.1021/jm00105a007. J Med Chem. 1991. PMID: 1992140

5

Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection.

Le Pecq JB, Gosse C, Nguyen-Dat-Xuong, Cros S, Paoletti C. Le Pecq JB, et al. Among authors: cros s. Cancer Res. 1976 Sep;36(9 pt.1):3067-76. Cancer Res. 1976. PMID: 975074

6

Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).

Macquet JP, Cros S, Armand JP. Macquet JP, et al. Among authors: cros s. Cancer Res. 1984 Sep;44(9):3736-43. Cancer Res. 1984. PMID: 6540142

7

Transgenic mice expressing the Sh ble bleomycin resistance gene are protected against bleomycin-induced pulmonary fibrosis.

Weinbach J, Camus A, Barra J, Dumont P, Julian M, Cros S, Babinet C, Tiraby G. Weinbach J, et al. Among authors: cros s. Cancer Res. 1996 Dec 15;56(24):5659-65. Cancer Res. 1996. PMID: 8971172

8

Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.

DeMarini DM, Cros S, Paoletti C, Lecointe P, Hsie AW. DeMarini DM, et al. Among authors: cros s. Cancer Res. 1983 Aug;43(8):3544-52. Cancer Res. 1983. PMID: 6344986

9

Experimental antitumor activity of Navelbine.

Cros S, Wright M, Morimoto M, Lataste H, Couzinier JP, Krikorian A. Cros S, et al. Semin Oncol. 1989 Apr;16(2 Suppl 4):15-20. Semin Oncol. 1989. PMID: 2711203 No abstract available.

10

The antitumor activity of some palladium(II) complexes with chelating ligands.

Wimmer FL, Wimmer S, Castan P, Cros S, Johnson N, Colacio-Rodrigez E. Wimmer FL, et al. Among authors: cros s. Anticancer Res. 1989 May-Jun;9(3):791-3. Anticancer Res. 1989. PMID: 2764525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters